adapting to disability

Disease Spotlight

Losing your sight is every bookworm’s worst nightmare, but former English teacher Paula Morandi has not let her diagnosis hold her back.

News

City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.